Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis
Clinical trial NCT06825312 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06825312
- Sponsor
- Liaoning Chengda Biotechnology CO., LTD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-11
- Primary completion
- 2030-12-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.